Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cerebrospinal fluid concentrations of naproxen and flurbiprofen in children
2006-000310-20Phase 4Completed
- Sponsor
- Hannu Kokki
- Start
- Jan 2006
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of naproxen and flurbiprofen axetil in postoperative pain (2 arms), sponsored by Hannu Kokki. Primary endpoints: Cerebrospinal fluid drug concentration at 15 minutes, Cerebrospinal fluid drug concentration at 60 minutes and 1 more. Started Jan 2006; status: completed.
02
Drugs
naproxenflurbiprofen axetil
03
Conditions
postoperative pain
Beyond the preview
Go deeper on 2006-000310-20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-000310-20.